MedTrace Logo

The Use of Cannabinoid Patch for Knee Osteoarthritis

NCT04412837 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2023-01-19

No results posted yet for this study

Summary

This randomized, double-blind 2-arm parallel group study to determine the efficacy of a cannabinoid (CBD) patch on reducing pain in patients with knee osteoarthritis.

Conditions

Interventions

DRUG

Topical CBD Patch

35 mg CBD patch

OTHER

Placebo Patch

Identical patch without active ingredient.

Sponsors & Collaborators

  • Solace Brands, Inc.

    collaborator UNKNOWN

  • Northwell Health

    lead OTHER

Principal Investigators

  • Vijay Rasquinha, MD · Northwell Health

  • Robert Duarte, MD · Northwell Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-12-31
Completion
2024-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412837 on ClinicalTrials.gov